PAGE 32 | THE CARER DIGITAL | ISSUE 53
MEDICATION MANAGEMENT
Omnicell's eMAR Solution Helping Care Homes to Manage Their COVID-19 Vaccination Programmes As the COVID-19 vaccination programme is being rolled out across the UK, Omnicell’s eMAR solution has recently been enhanced to help support care homes to manage recording of the medication in terms of timings, dosage as well as the type of vaccination used. As with any other medication, this vaccine needs to be managed and administered safely. New features to the eMAR care home solution have been introduced to ensure that staff can easily record the type of vaccine, when it was administered and whether it was the first or second injection. As with all medication, residents have the right to refuse and should that be the case, the Omnicell eMAR solution also captures this information too. The Omnicell eMAR system automates the entire medication management and administration process for each care home resident, ensuring they receive their right medication at the right time. Now, care home management and staff can have the COVID-19 vaccine status of each resident at the touch of their fingertips as part of the eMAR Reporting Suite. The eMAR system gathers information, provides prompts and accurate instructions for staff and managers in real time at the touch of a button. Each individual medication is identified through a barcode, normally applied in pharmacy, which can then be tracked at all stages from check in at the care home through to administration to a resident. It provides an invaluable medicines history for each patient and includes a simple alert and verification system to minimise the risk of medication errors in the home. Residents in care homes take an average of 7.2 medicines per day. With each additional medicine comes an increased risk of errors in prescription, monitoring, dispensing or administration, adverse drug reactions, impaired medicines adherence which can lead to compromised quality of life for
patients. CQC’s annual state of care report found that safety was the biggest concern with one of the main contributing factors being poor medicines management.1 Recently, Omnicell UK, the market leader in medication and supplies automation, and Nourish Care, a leading electronic care planning provider, came together to provide a new integration that gives care staff greater visibility of a patient’s medication regime as part of their overall care plan. Managing and monitoring resident’s medication regimes effectively can significantly impact the delivery and quality of care. Historically care plan-
ning and medication administration systems have been managed completely separately. This can potentially contribute to failings in support of residents’ care. The new integration means that Omnicell eMAR can now share data related to medication with the Nourish Care system, giving greater insight and driving best practice into the safety and individual care of each resident in the home. Heather Bethune, Care Home Manager at Abbeyfield House Care Home, comments; "The new COVID-19 recording feature has been a huge help for our care home. All of the vaccine information is recorded in one place and it's presented alongside all the medication that we've administered - where it should be, so it's great to have a simple overview of everything that’s medication related. We can record the type of vaccine that resident has been given and the date they were administered it, this allows us to know when the second vaccination is required for each resident. The system allows you to input information retrospectively which is a great help when we have new residents join the home who have already had the vaccine. It's a really simple and easy to use system that is helping us to manage the COVID-19 virus.” Cyrus Hodivala, Medicines Adherence Sales Director at Omnicell UK & Ireland, comments; “Here at Omnicell we are constantly looking at new ways to respond to our clients needs with innovative solutions. And as such, we are pleased to announce the new features and enhancements to our eMAR solution which will help support care homes to manage their COVID-19 vaccination programmes. We anticipate that this will help to drive much needed times efficiencies for staff during this difficult time, as well as ensure patient safety within the care sector.” For further information contact www.omnicell.co.uk/products/emar
ATLAS eMAR - The Only Proven eMar for Care Homes in the UK ATLAS eMAR is the only independently evaluated medication administration system that has been shown to eradicate 21 out of 23 medication error types, save 65 staff hours per month on medication, representing over £1500 savings per month and improve accountability by reducing missing entries by 85%. There are four unique features of ATLAS eMAR: 1. Use of barcode validation to ensure all the rights of medicine administration are checked. This feature eradicates most common medication errors. 2. Automatic two-way link between the pharmacy and care home. This ensures that the pharmacy is aware of therapy changes made at the home and can sort out discrepancies with prescriptions before they become errors. The pharmacy can also see all prescription requests and the actual stock counts of each medicine at the care home. This leads to efficiencies in ordering, booking in and returning of medicines.
3. The data from ATLAS eMAR on medication administrations can now be viewed on most e-care planning platforms through our open API. This means that all aspects of resident care including medications can now be viewed in one place. 4. ATLAS eMAR can now be used on any suitable android device. This means that if you already have an android device for e-care plans, then you can run ATLAS eMAR on it, making it a very cost effective option. ATLAS eMAR has a national network of enabled pharmacies and can work with any pharmacy, as long as they agree to support the care home with the technology. The implementation is detailed and fully supported. Training is via on-line elearning and webinars. Over 95% of care homes who implemented ATLAS eMAR indicated that they would never go back to their traditional medication system. Visit www.atlasemar.com or see the advert on page 44 for further details.
®
Well Pharmacy Partners with PainChek to Promote Person-Centred Care Well Pharmacy, the UK’s largest independent pharmacy chain, is pleased to announce a partnership with PainChek®, the world’s first AI-powered pain assessment tool to help people who are unable to verbalise if they have pain, such as those living with dementia. Sadly, pain often goes un-detected and under-treated in people with communication difficulties from medical conditions. The Well Care Home Services Team are actively signposting more than 350 care homes across the UK to use PainChek® as an effective solution to help measure pain in residents and promote the highest standards of care in residential homes. This secure medical device is simple and straightforward to use via mobile or tablet. It uses artificial intelligence (facial detection and analysis technology) and smart automation to detect and score pain in real time allowing informed clinical decisions around appropriate and effective pain management to be made. This partnership further highlights how Well Pharmacy are committed to offering a local community service with a real focus on person-centred care, quality and safety. Tandeep Gill, Care Home Business Lead at Well Pharmacy said: “Well Pharmacy is delighted to partner with PainChek®. At Well we strive to offer an outstanding local service to care homes and their residents. PainChek® uses innovative technology to help residents who are not able to communicate for themselves to identify
the presence of pain. “We’re delighted that through this partnership we are able to pass on an exclusive discount to benefit our care homes customers across the UK, so they can help improve the quality of life for their residents and offer person-centred care.” Pete Shergill, PainChek® UK&I Country Director said: “About half of people living with dementia suffer from pain, but they are often unable to verbalise they have pain, and sadly, it goes unmanaged and untreated. “Ensuring residents’ pain is assessed effectively is critical for care home operators, healthcare professionals and carers but it can be challenging. Therefore, we are really pleased that Well Pharmacy is partnering with us to promote and deliver a quick and easy-to-use solution that will allow carers and healthcare professionals to measure pain in residents, document checks and make informed clinical decisions for effective pain management. “By harnessing the power of medtech, care providers can deliver more efficient and effective care, streamline processes, and ultimately cut costs and save time – allowing staff to focus on delivering the highest standard of care.” For more information, about Well Pharmacy’s Care Home Service please visit www.well.co.uk/carehomes For more information about PainChek® email: info@painchek.com or visit: https://painchek.com/uk/